Zdrowie i gospodarka · 28/04/2017

FDA Reopens Comment Period for Pharmaceutical Distribution Supply Chain Pilot Projects

The FDA is reopening the comment period for the Request for Information regarding the utilization of product identifiers for product tracing, supply chain technical capabilities, and system attributes necessary for implementing the Drug Supply Chain Security Act (DSCSA). The reopened comment period aims to gather updated comments and new information to inform the design and development of pilot projects under the DSCSA.